Podcast appearances and mentions of Robert M Wachter

The gig was up, but when he finally got COVID, it was pretty far down on his ER problem list. This podcast is intended for US healthcare professionals only. To read a full transcript of this episode or to comment please visit: https://www.medscape.com/features/public/machine Eric J. Topol, MD, Director, Scripps Translational Science Institute; Professor of Molecular Medicine, The Scripps Research Institute, La Jolla, California; Editor-in-Chief, Medscape Abraham Verghese, MD, Physician, author, and educator; Professor and Vice Chair, Theory & Practice of Medicine, Department of Medicine, Stanford University, Stanford, California The Covenant of Water, Abraham Verghese, MD; https://www.abrahamverghese.org/books/ Robert M. Wachter, MD, Professor and Chair, Department of Medicine, University of California, San Francisco https://twitter.com/Bob_Wachter You may also like: Medscape's Chief Cardiology Correspondent Dr John M. Mandrola's This Week In Cardiology https://www.medscape.com/twic Discussions on topics at the core of cardiology and the practice of medicine with Dr Robert A. Harrington and guests on The Bob Harrington Show https://www.medscape.com/author/bob-harrington For questions or feedback, please email: news@medscape.net

Thanks for joining us for episode 50! While AI breakthroughs slowed down this week, insights, best practices, and conversations continued. Paul Roetzer and Mike Kaput catch up on the artificial intelligence news impacting marketing and business leaders. OpenAI dropped chat prompt suggestions Logan Kilpatrick from OpenAI gave us helpful tips on crafting prompts. Quite simply (or so it seems), Kilpatrick offers six strategies for getting better results: write clear instructions, provide reference text, split complex tasks into simpler subtasks, give GPTs time to "think", use external tools, and test changes systematically. Is it that easy? What has OpenAI learned, and how can marketers follow these strategies while still differentiating themselves?  Could generative AI transform healthcare?  Could generative AI transform healthcare for the better? One expert thinks so. Dr. Robert M. Wachter, professor, and chair of the Department of Medicine at the University of California, San Francisco, outlines why in a new essay commissioned by Microsoft. In it, Dr. Wachter says he's optimistic that generative AI systems like GPT-4 have the potential to reshape how healthcare works. This article caught Paul's attention, and Paul and Mike break it down on the podcast, discussing not only marketing but also better patient outcomes and a reduction in healthcare costs.  High costs and AI adoption According to a new report from The Information: “More than 600 of Microsoft's largest customers, including Bank of America, Walmart, Ford, and Accenture, have been testing the AI features in its Microsoft Office 365 productivity apps, and at least 100 of the customers are paying a flat fee of $100,000 for up to 1,000 users for one year, according to a person with direct knowledge of the pilot program.” The proposed pricing models for AI features will impact business leaders' decision-making regarding AI adoption, especially small businesses. This helpful episode of The Marketing AI Show can be found on your favorite podcast player and be sure to explore the links below.

Robert M. Wachter, MD is Professor and Chair of the Department of Medicine at the University of California, San Francisco (UCSF). In 2021-22, the Department was ranked the best internal medicine department in the nation by U.S. News & World Report. Wachter is the author of 300 articles and 6 books. He coined the term “hospitalist” in 1996 and is often considered the “father” of the hospitalist field, the fastest growing medical specialty in U.S. history. See omnystudio.com/listener for privacy information.

Robert M. Wachter, MD is Professor and Chair of the Department of Medicine at the University of California, San Francisco (UCSF). In 2021-22, the Department was ranked the best internal medicine department in the nation by U.S. News & World Report. Wachter is the author of 300 articles and 6 books. He coined the term “hospitalist” in 1996 and is often considered the “father” of the hospitalist field, the fastest growing medical specialty in U.S. history. See omnystudio.com/listener for privacy information.

Robert M. Wachter, MD, Professor and Chair, Dept. of Medicine of UCSF joins the show to answer all questions COVID-19. See omnystudio.com/listener for privacy information.

Robert M. Wachter, MD is Professor and Chair of the Department of Medicine at UCSF, where he is the Holly Smith Distinguished Professor in Science and Medicine and the Benioff Endowed Chair in Hospital Medicine. He coined the term “hospitalist” in 1996 . In 2015, Modern Healthcare magazine named him the most influential physician-executive in the United States. Prior to becoming UCSF's ninth chair of medicine, he served as chief of UCSF's Division of Hospital Medicine. He is generally regarded as the academic leader of the hospitalist movement. Hospitalists are internists and other physicians who specialize in the care of hospitalized patients. He is a past president of the Society of Hospital Medicine and a past chair of the American Board of Internal Medicine. In January 2021, Wachter began guest-hosting the In the Bubble podcast. You can follow Bob on twitter. Patricia C Henwood MD is an Associate Professor of Emergency Medicine at Thomas Jefferson in Philadelphia. She has been leading and organizing the coronavirus response on the front lines at Jefferson and in the city of Philadelphia. Trish's experience training clinicians in Rwanda, Uganda, and other countries to use point-of-care ultrasound to answer questions about TB, and Ebola has prepared her more than most on how to handle a crisis. Trish is a graduate of the Harvard Affiliated Emergency Medicine program. During her time as a resident she founded a 401(c)3 organization PURE: Point-of-care Ultrasound in Resource limited Environments. PURE is an organization comprised of medical professionals and others dedicated to enhancing ultrasound education and use in the developing world. PURE works in concert with ministries of health and local leaders in education to develop tailored plans to train physicians and other healthcare practitioners to use ultrasound at the bedside in caring for their patients, as well as help them develop the tools to sustainably transfer ultrasound skills to other healthcare practitioners in their setting. In a 2019 NEJM perspective piece, Trish published her never before described ultrasound findings diagnostic of Ebola patients in Liberia. Follow Trish on twitter.

To get more vaccine to more people more efficiently, UCSF School of Medicine's Robert M. Wachter, MD, recently urged giving a single dose now and deferring the second dose until more vaccine is available. Paul A. Offit, MD, of The Children's Hospital of Philadelphia, disagrees. The two discuss the pros and the cons of the plan and alternative responses to road bumps in the US vaccine rollout, on JAMA's live Q&A series. Recorded January 19, 2021. Related Article: Developing a SARS-CoV-2 Vaccine at Warp Speed

To get more vaccine to more people more efficiently, UCSF School of Medicine's Robert M. Wachter, MD, recently urged giving a single dose now and deferring the second dose until more vaccine is available. Paul A. Offit, MD, of The Children's Hospital of Philadelphia, disagrees. The two discuss the pros and the cons of the plan and alternative responses to road bumps in the US vaccine rollout, on JAMA's live Q&A series. Recorded January 19, 2021. Related Article: Developing a SARS-CoV-2 Vaccine at Warp Speed

ONR producer host Julia Dudley Najieb reviewed the latest MLK events happening throughout California. Thereafter Dudley Najieb reviewed the challenges of vaccine distribution with two experts Dr. Robert M. Wachter and Dr. William Schaffner.

“As I heard story after story after story, I realized we were going to see a ton of gaming, it’s going to be less efficient and inequitable, and I think a lot of us felt like this is too complicated,” Jha, , said Tuesday during taping of the 12th episode of “COVID: What Comes Next,” the weekly Providence Journal/USA TODAY NETWORK podcast.  Jha reaffirmed his advocacy for first vaccinating high-risk healthcare and other frontline workers, residents and staffs of nursing homes, and people living who live with underlying conditions. But even as states prioritize other groups, Jha said “the implementation is going to really just kill us, it's going to slow us way down and it's not going to be done well.”  The Brown dean first publicly proposed a lottery system in a Sunday New York Times op-ed essay cowritten with Dr. Robert M. Wachter, chairman of the University of California at San Francisco’s department of medicine. The two physicians have also called for single-dose use of the Pfizer and Moderna vaccines so that more people can quickly receive a degree of immunity, with the recommended second doses delayed.   Jha and Wachter recommended that after front-line workers, nursing home residents and staff, and people with co-morbidity have been vaccinated, likely by the end of this month, all people should be vaccinated “from oldest to youngest.” After that, they wrote, “to determine the order for the remaining 150 million or so American adults, use a lottery.”  On the “COVID: What Comes Next” podcast, Jha said “just make it something super simple like a lottery. It won't be perfect but it'll be much better than what is likely to be implemented.”  Also on the podcast, Jha discussed the likelihood that Wednesday’s riot at the Capitol will become a superspreader event. Already, two Congresswoman who were inside the building when the pro-Trump mob broke in have been infected with coronavirus disease, which they trace to the Wednesday riot.   Jha also assessed the merits of mass-vaccination sites. Stadiums, California’s Disneyland, and other venues have recently begun offering the two approved vaccines to large numbers of people. The Brown dean then discussed two vaccines in development but not yet approved for use in the U.S.: The Astra-Zeneca and Johnson & Johnson products.  And the pandemic expert also answered an audience question from a scientific researcher who wrote to the podcast “in frustration of those around me who refuse to or are hesitant to take the vaccine. I am hoping you can offer some advice on how to approach these individuals. I understand that this issue is more related to scientific communication and public health as a whole, but how can we work towards communicating to our loved ones about the safety and efficacy of this amazing research?”  If you have a COVID-related question, please send to gwmiller@providencejournal.com with “Question for Dr. Jha” in the subject field. Dr. Jha will get to as many questions as he can, but regrettably, given the volume, he cannot get to all. And please note Dr. Jha’s advice: Questions regarding one’s personal situation should be put to your healthcare provider.  This weekly podcast is hosted by G. Wayne Miller, health reporter for The Providence Journal. See omnystudio.com/listener for privacy information.

The U.S. is stumbling out of the gate in getting the COVID-19 vaccine distributed in 2021, as a more contagious variant of the virus spreads around the country. Dr. Robert M. Wachter, the head of the department of medicine at the University of California at San Francisco, joins William Brangham to discuss the vaccine rollout, and why he thinks the U.S. should delay a second round of COVID doses. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

The U.S. is stumbling out of the gate in getting the COVID-19 vaccine distributed in 2021, as a more contagious variant of the virus spreads around the country. Dr. Robert M. Wachter, the head of the department of medicine at the University of California at San Francisco, joins William Brangham to discuss the vaccine rollout, and why he thinks the U.S. should delay a second round of COVID doses. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders

Dr. Robert M. Wachter is a professor and chair of UC San Francisco Department of Medicine. The author of more than 300 articles and six books, he’s been ranked as one of the most influential physician-executives in the U.S. He discusses California’s original success in dodging the Covid-19 bullet, and why it now may be catching up with us. He discusses how much smarter we’ve become in four months, how much longer Covid-19 may be with us, and how medicine will be transformed forever.

Interview with Robert M. Wachter, MD, author of Reimagining Specialty Consultation in the Digital Age: The Potential Role of Targeted Automatic Electronic Consultations

Interview with Robert M. Wachter, MD, author of Restricting the Number of Open Patient Records in the Electronic Health Record: Is the Record Half Open or Half Closed?

Sherri Douville brings over a decade in healthcare consulting, sales, marketing, and entrepreneurial experience to her leadership at Medigram.  She now serves as a frequent moderator and panel coach at Health IT conferences.  Prior to this, she founded a healthcare technology consulting practice.  Medigram is a mobile, intelligent enterprise solution for healthcare that enables clinicians to communicate securely and efficiently, with intelligent context and images wherever they are, via the Medigram iOS app, Android app, or web client.  As CEO for Medigram, Sherri has successfully planned and executed on the development, design, and build of the enterprise grade version platform, Medigram 2.0, which is based on an independent, secure and scalable database.  This allows for the Medigram 2.0 platform to flexibly adapt to evolving healthcare business requirements. Sherri has experience in over a dozen disease states from over 9 years in clinical sales at Johnson & Johnson where she participated in the management development program, won a number of awards, and was recognized as an industry leader by Standard & Poor's Vista Research division while it was part of McGraw-Hill. Sherri now serves on the Board for HIMSS Northern California where she is Co-Chair for the Innovation conference, Co-Chair for program panels, and contributes to the newsletter. She is an advisory board member for the National Bundled Payment Collaborative, serves as a member of Santa Clara University's Board of Fellows, and as Co-Chair of the mentoring team at TiE's (The Indus Entrepreneur) youth entrepreneurship program.  She earned her BS degree in Combined Sciences from Santa Clara University and two big data analytics certificates through MIT.  Sherri recharges while exercising, reading, writing, and by spending time with her husband and friends cooking, hiking, and learning together. President & CEO, Medigram, Inc. Email: sherri@medigram.com www.medigram.com www.linked.com/in/sdouville https://medium.com/@SherriDouville https://www.peerlyst.com/users/sherri-douville   @SherriDouville @Medigram 00:00 How we should be thinking about ‘sure' things. 03:00 Managing and Focusing on underlying improvements that will stay the same, no matter what the end goal becomes. 03:45 Where Bundled Payments falls in the certain vs. uncertain future. 06:20 “If you don't have information that's stuck in silos, then there's no possible way you can coordinate care.” 07:50 Possible name changes and delays, but why Bundled Payments will go on in some way, shape, or form. 09:30 Coordinating Care across settings and having Interoperability. 10:00 How Medigram makes all of these worries easier. 10:45 A Medigram use case. 11:45 How Medigram facilitates communication between Care Settings. 15:40 “Just because it works on a computer doesn't mean it's going to work on a mobile app.” 19:30 “It's all about driving context.” 20:00 “The Digital Doctor,” by Robert M. Wachter. 22:50 Where a text in Medigram goes, and where it winds up. 27:00 Sherri gives some advice to potential Health Tech creators. 28:45 “To succeed in the current environment it's important to be really specific.” 29:40 You can find out more information by searching Sherri Douville on LinkedIn and Medium.

Interview with Daniel J. Elliott, MD, MSCE, author of Effect of Hospitalist Workload on the Quality and Efficiency of Care, and Robert M. Wachter, MD, author of Hospitalist Workload: The Search for the Magic Number

Guest - Dr. Robert M. Wachter - Professor and Associate Chair of the Department of Medicine at the University of California offers his sage advice about patient safety and the patient experience.Healthcare Hazard of the Week - Are your medications falling off the patent cliff this year? Hmm ... better listen and find out.Game Time - The boys go back to our roots - FEAR THE WHEELCHAIR makes a comeback.This show is broadcast live on W4CY Radio (www.w4cy.com) part of Talk 4 Radio (http://www.talk4radio.com/) on the Talk 4 Media Network (http://www.talk4media.com/).

Special interview by Howard Bauchner, MD, Editor in Chief of JAMA, with Robert M. Wachter, MD, and Abraham Verghese, MD, MACP, authors of The Attending Physician on the Wards: Finding a New Homeostasis